FDA Adverse Event Death Summary report: N

CARELINK SMARTSYNC COMMON APP IOS

MDR report key: 21419798 · Received February 20, 2025

Report

Report Number
2182208-2025-00905
Event Type
Death
Date Received
February 20, 2025
Date of Event
January 31, 2025
Report Date
April 15, 2025
Manufacturer
MEDTRONIC, INC.
Product Code
DTC
PMA / PMN Number
P890003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION FDC CODE H6 MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

PRODUCT ANALYSIS: PERFORMANCE DATA COLLECTED FROM THE MOBILE PROGRAMMER WAS RECEIVED AND ANALYZED.  ANALYSIS OF THE DATA/DATABASE FOUND THE CUSTOMER COMMENT THAT THE MOBILE PROGRAMMER APPLICATION PROMPTED THAT AN UPDATE WAS REQUIRED WAS CONFIRMED. ANALYSIS OF THE DATA/DATABASE FOUND THE CUSTOMER COMMENT THAT THE UPDATE TOOK LONGER THAN EXPECTED COULD NOT BE CONFIRMED. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE MOBILE PROGRAMMER APPLICATION PROMPTED THAT AN UPDATE WAS REQUIRED WHEN ATTEMPTING TO INTERROGATE A PATIENT THAT WAS "CODING". THE UPDATE WAS INITIATED, HOWEVER THE UPDATE WAS TAKING LONGER THAN EXPECTED RESULTING IN THE NECESSITY TO SWAP OUT THE MOBILE PROGRAMMER APPLICATION. THE INTERROGATION WAS THEN SUCCESSFULLY COMPLETED WITH THE REPLACEMENT MOBILE PROGRAMMER APPLICATION, HOWEVER THE PATIENT SUBSEQUENTLY PASSED AWAY. IT WAS REPORTED THAT THE PATIENT DEATH WAS NOT DUE TO THE APPLICATION UPDATE. IT WAS NOTED THAT DISSATISFACTION WAS EXPRESSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
424734 CARELINK SMARTSYNC COMMON APP IOS ANALYZER, PACEMAKER GENERATOR FUNCTION DTC MEDTRONIC, INC. M01A02

Patients

Seq Age Sex Outcome Treatment
1 74 YR Male Required Intervention| D